You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Transdermal Cannabidiol Delivery for Alcohol-Induced Neurodegeneration

    SBC: ALLTRANZ, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Treatment of alcohol use disorders (AUDs), commonly referred to as alcoholism, has been hampered by alcohol's promiscuous pharmacological effects and the complex etiology of addiction. People drink in excess for a variety of reasons, and an approach that targets more of these reasons will have greater commercial success than an approach that only targets a sole ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  2. ApoVax-SVN as a Novel Vaccine for Cancer Immunotherapy

    SBC: APOIMMUNE, INC            Topic: N/A

    DESCRIPTION (provided by applicant): The main objective of this proposal is to develop a novel cancer vaccine, ApoVax-SVN(tm) based on the use of a proprietary costimulatory chimeric ligand, 4-1BBL, designed to specifically deliver survivin, a tumor associated antigen (TAA) to professional antigen-presenting cells (APCs) and activate them for the generation of an effective anti-tumor immune respon ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  3. Automated Test of Word Recognition- Phase II

    SBC: AUDIOLOGY, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Over 5 million word recognition tests are administered annually by audiologists in the United States with an associated cost of more than $100 million. These tests are currently performed manually by highly trained audiologists. This application describes the Phase II development of automated clinical speech recognition tests using clinical test recordings and ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  4. Audiometric Earphone- Phase 1

    SBC: AUDIOLOGY, INC            Topic: N/A

    DESCRIPTION (provided by applicant): This project seeks to develop an earphone for diagnostic audiometry with features that will significantly increase the efficiency and decrease the cost of routine hearing testing. The most-often used earphones emply a supra-aural design that has several undesirable characteristics, including 1) an "occlusion effect", an artificial increase in sensitivity to bon ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  5. Development of Improved Earphone for Hearing Testing

    SBC: AUDIOLOGY, INC            Topic: N/A

    DESCRIPTION (provided by applicant): This project seeks to develop an earphone for diagnostic audiometry with features that will significantly increase the efficiency and decrease the cost of routine hearing testing. The most-often used earphones employ a supra-aural design that has several undesirable characteristics, including 1) an "occlusion effect", an artificial increase in sensitivity to bo ...

    STTR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  6. Targeted Transposons for Gene Therapy

    SBC: DISCOVERY GENOMICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Discovery Genomics, Inc. is focused on development of the Sleeping Beauty (SB) transposon system as a non-viral means of integrating new gene sequences in cells and tissues for therapeutic purposes. Here we propose to develop a method for improved targeting of the SB system to specific cell types following systemic injection by coupling a targeting tether to th ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  7. New anti-complement therapy to reduce reperfusion injury

    SBC: ENDOPROTECH, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The purpose of this proposal is to provide proof-of-concept that a novel therapy that prevents complement activation could be effective in reducing ischemia reperfusion injury (IRI) in transplanted organs. Complement activation after IRI in transplanted organs is a well-known phenomenon that may be responsible for delayed graft function and the hastening of ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  8. Internet Savvy Caregiver: Dementia Training and Planner

    SBC: HEALTHCARE INTERACTIVE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The overall goal of the Internet-Based Savvy Caregiver (IBSC) program is to develop and bring to market an Internet-based psycho-educational program designed to provide persons caring for relatives who have dementing disorders the knowledge, skills, and outlook they need to undertake and succeed in the caregiving role they have assumed. The IBSC program is comp ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  9. Rapid Bacterial Detection in Platelet Concentrates

    SBC: Medical Innovations International, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): A rapid detection system can be readily developed to prevent bacterial contamination in platelet concentrates that are intended for transfusion. Bacteria contamination of platelet concentrates intended for transfusion, represents the most frequent transfusion-associated infectious risk. Bacterial contamination levels as low as 102 to 103 CFU/ml have been ass ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  10. Rapid Detection of Aspirin Resistance in Human Subjects

    SBC: Medical Innovations International, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The number of patients treated with antiplatelet agents increases annually. It is reported that over 20 million people in the U.S. alone take aspirin daily to induce some level of platelets inhibition. Clinical data shows that not all patients receive the full benefits of aspirin, and that a large patient to patient variability exists in aspirin induced platele ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government